Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bodi Envi vs ReadyRx

By GLP-1 ScorecardUpdated

Bodi Envi
Site position #97

Higher grade

ReadyRx
Site position #173

Lower grade

Score comparison

Bodi Envi has the higher recorded score — 71.8/100 to 67.8/100.

Bodi Envi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bodi Envi is a nationwide telehealth weight-loss provider offering physician-prescribed compounded semaglutide ($179/month) and tirzepatide ($249/month) at flat all-dose pricing with no consultation or membership fees.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueBodi Envi +12
73
61
Dose & formulationBodi Envi +8
72
64
Clinical oversightBodi Envi +3
82
79
Labs & monitoringEven
64
64
FulfillmentReadyRx +14
69
83
Contract termsBodi Envi +6
61
55
Bodi Envi · top barReadyRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBodi EnviReadyRx
WeighScore71.8/10067.8/100
GradeCC
Site position#97#173
Semaglutide$179/mo$179/mo (starting dose, compounded)
Tirzepatide$249/mo$255/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Bodi Envi

Site position #97 · C

Strengths

  • Transparent flat pricing: compounded semaglutide $179/month and tirzepatide $249/month, all doses
  • No consultation or membership fees
  • Free 2-day shipping included; FSA and HSA eligible
  • 24/7 secure provider messaging with same-day visits and prescriptions
  • Personalized dose titration with side-effect management (Zofran available)

What to consider

  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No insurance billing — cash-pay only
  • States served are not explicitly listed (features vary by state)
  • No LegitScript certification visible on the site
ReadyRx

Site position #173 · C

Strengths

  • LegitScript Certified — verifiable via the badge link in the footer
  • Batch lab testing covers the right QA metrics for injectables: potency, sterility, pH, and endotoxicity
  • Pricing shown publicly: $179/mo semaglutide, $255/mo tirzepatide

What to consider

  • Pharmacy partners not named — only described as 'FDA-registered compounding pharmacies'
  • Clinicians described as licensed and board-certified, but no names or credentials published
  • 5,000+ member figure comes from a directory listing, not an independent audit

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard